The Clinical Role of Insulin Degludec/Insulin Aspart in Type 2 Diabetes: An Empirical Perspective from Experience in Australia

Treatment intensification in people with type 2 diabetes following failure of basal insulin commonly involves the addition of a rapid-acting insulin analogue (basal plus one or more prandial doses; multiple daily injections) or by a switch to premixed insulin. Insulin degludec/insulin aspart (IDegAs...

Descripción completa

Detalles Bibliográficos
Autores principales: Glastras, Sarah J., Cohen, Neale, Dover, Thomas, Kilov, Gary, MacIsaac, Richard J., McGill, Margaret, Fulcher, Greg R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230791/
https://www.ncbi.nlm.nih.gov/pubmed/32290465
http://dx.doi.org/10.3390/jcm9041091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230791/
https://www.ncbi.nlm.nih.gov/pubmed/32290465
http://dx.doi.org/10.3390/jcm9041091

Ejemplares similares